About S1P Therapeutics
S1P Therapeutics is a private company based in Blacksburg, Virginia, incorporated in 2019 in Delaware. It has reported $2,016,999 raised in one offering on Form D since June 2023. Its chief executive is Ronald Sayco.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 31, 2023 | Jun 9, 2023 | $2,016,999of $3.0M target | 1 | $2.0M | EquityRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on S1P Therapeutics's Form D filed Jun 9, 2023.
KL
Kevin Lynch
Executive officer and director
WS
Webster Santos
Executive officer and director
RS
Ronald Sayco
Chief Executive Officer and director